New concepts in blood pressure-lowering management in diabetic patients: the case for early ACE inhibitor combination therapy with diuretics (Q36216253)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	New concepts in blood pressure-lowering management in diabetic patients: the case for early ACE inhibitor combination therapy with diuretics	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

New concepts in blood pressure-lowering management in diabetic patients: the case for early ACE inhibitor combination therapy with diuretics (English)

1 reference

Europe PubMed Central

12 August 2017

author name string

Mogensen CE

1

1 reference

Europe PubMed Central

12 August 2017

publication date

1 June 2005

1 reference

Europe PubMed Central

12 August 2017

Journal of Human Hypertension

1 reference

Europe PubMed Central

12 August 2017

19 Suppl 1

1 reference

Europe PubMed Central

12 August 2017

S15-20

1 reference

Europe PubMed Central

12 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1001888

0 references

The metabolic syndrome and chronic kidney disease in U.S. adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Impact of high-normal blood pressure on the risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Old antihypertensives and new diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Metabolic issues in the Antihypertensive and Lipid-Lowering Heart Attack Trial Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Randomized placebo-controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Preventing microalbuminuria in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Angiotensin II receptor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

21 January 2018

Antihypertensive therapy and incidence of type 2 diabetes in an elderly cohort

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetics and diabetic renal disease: still a big black hole

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001888

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.JHH.1001888

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36216253&oldid=1994705928"